EXUMA Biotechnology

  • Our Science Expand
      back
    • Tumor Metabolism Regulated CAR-T
    • Cell & Gene Therapy Delivery Systems
    • Analytics
  • Pipeline
  • Our Company Expand
      back
    • Strategic Relationships
    • Our Team
  • News & Resources Expand
      back
    • Posters
    • Presentations
  • Careers Expand
      back
    • Job Openings
  • Contact
Skip to content
September 24 2020October 1, 2020 by Alissa Kerner

Speeding the Delivery of CAR-T Therapies While Cutting the Cost

Chairman & CEO Greg Frost speaks with Danny Levine from The BIO Report on making CAR-T therapies more accessible and affordable for patients

The Bio Report podcast, hosted by award-winning journalist Daniel Levine, focuses on the intersection of biotechnology with business, science, and policy.

 

The Bio Report · Speeding the Delivery of CAR-T Therapies While Cutting the Cost
  • Jobs
  • Legal
    • LinkedIn
    • Twitter
  • ©2022 EXUMA Biotechnology